Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q4 2018 Earnings

7MarExpected

Q1 2018

Q2 2018

Q3 2018

Q4 2018

-15.5

-10.45

-5.41

-0.36

Details

Expected EPS

-0.37

Actual EPS

-15.5

Surprise EPS

-15.13

Surprise Percent

+4,089.19%

Description

Spyre Therapeutics (SYRE) has reported earnings of -15.5 per share for Q4 2018.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.